ALUMNI

1968

Barbara Wasserman and Martin Wasserman (faculty, pediatrics 1976–77) were recognized with the Compassion in Medicine Award from the Physicians Committee for Responsible Medicine. Founded in 1985, the organization aims to improve human and animal lives through plant-based diets and ethical and effective scientific research.

1977

Dolores Shoback (fellow, medicine, 1977–81), professor of medicine and the associate program director at the University of California San Francisco’s physician training program, received the Outstanding Scholarly Physician Award from the Endocrine Society. This award recognizes those who have made outstanding contributions to clinical endocrinology in academic settings.

1989

Mathias Bostrom was named associate surgeon-in-chief at the Hospital for Special Surgery, where he will also serve as director of quality and safety. Since 2019, he has served as chief of adult reconstruction and joint replacement at the hospital.

1991

Peter Pronovost (fellow, anesthesiology, 1991–97; faculty, 1997–present [adjunct]), the chief quality and clinical transformation officer and the Veale Distinguished Chair in Leadership and Clinical Transformation at University Hospitals Health System in Cleveland, was named leader of the Veale Initiative for Health Care Innovation at University Hospitals. Established by a $10 million gift, the Veale Initiative aims to develop a novel approach to prioritize health care’s biggest problems and find solutions.

1992

Lawrence Sang-Il Kim was named the secretary/treasurer of the Accreditation Association for Ambulatory Health Care’s board of directors. Kim specializes in gastroenterology and currently serves as the vice president of the American Gastroenterological Association and on the board of directors for the Digestive Health Physicians Association.

David Bredt (M.D./Ph.D.; fellow, neuroscience, 1993–94) is the co-founder and chief scientific officer of Rapport, a clinical-stage biotechnology company leveraging the science of receptor-associated proteins to advance precision neuromedicines. In August 2023, the company raised $150 million in Series B financing to bring its total funding to $250 million. With over 20 years of neuroscience drug discovery experience, Bredt has led groundbreaking research in receptor-associated protein biology. He previously served as global head of neuroscience discovery at Janssen until 2021, as vice president of neuroscience at Eli Lilly and Company, and professor of physiology at the University of California San Francisco. He was elected to the Johns Hopkins University Society of Scholars in 2005.

1994

Rich Savel is chair of the Department of Medicine at Jersey City Medical Center, part of RWJBarnabas Health System.

2008

Sami Alom Ruiz (Ph.D.) serves as the CEO of Kasamar Holdings, a family office that invests in regional equity, global real estate and public securities. Until recently, he was the chief strategy officer and director of investor relations at the Al Noor Hospitals Group.

2009

Giannina Garces-Ambrossi Muncey was invited to join the Jack Kent Cooke Foundation’s BIPOC Scholar Alumni/Staff Advisory Council for 2023.

Ankit Mahadevia left his role as president and CEO of Spero Therapeutics, a multi-asset, clinical-stage biopharmaceutical company focused on developing novel treatments for infectious diseases. He now serves as the chair of the board at Spero Therapeutics and as a board member or adviser to biotech companies.

2022

Andrew Lea has authored Digitizing Diagnosis, a detailed history of the first efforts to computerize medical diagnosis and the moral debates around these efforts. (Read more in Media Matters.)

FORMER FACULTY, FELLOWS & RESIDENTS/HOUSE STAFF

Ephraim Fuchs (HS, 1985–88; fellow, 1988–94; faculty, oncology, 1994–present) has been appointed as the chief medical officer of ImmunoFree, a company that uses stem cell technology to eliminate the need for immunosuppressive medications. In this new role, he will oversee medical and scientific affairs, and lead the development of ImmunoFree’s tolerance protocol.

Michael Cabana (fellow, pediatrics, 1994–99) is the Academic Pediatrics Association’s 2023 Miller-Sarkin Research Mentoring Award recipient. This award recognizes outstanding mentorship to learners. He currently serves as professor and chair of pediatrics at the Albert Einstein College of Medicine, and as physician-in-chief at the Children’s Hospital at Montefiore.

Justin Hanes (fellow, neurosurgery, 1996–98; faculty, ophthalmology, 2009–present) has been elected to the National Academy of Medicine. He is the Lewis J. Ort Professor of Opthalmology and director of the Center for Nanomedicine at Johns Hopkins’ Wilmer Eye Institute, with joint appointments as professor of biomedical engineering, chemical and biomolecular engineering, neurosurgery, oncology, and pharmacology and molecular sciences.

Brian Krabak (faculty, physical medicine and rehabilitation, 1998–2007) served as team physician for the USA Swimming team during the 2023 Aquatics World Championships in Fukuoka, Japan. He has served as a USA Swimming team physician through the High Performance Network since 2009.

Deidra Candice Crews (HS, internal medicine, 2003–06; fellow, nephrology, 2006–09) has been elected to the National Academy of Medicine. A professor of medicine in the Division of Nephrology at Johns Hopkins, she holds faculty appointments with the school of nursing; the Welch Center for Prevention, Epidemiology and Clinical Research; the Center on Aging and Health; and the Center for Health Equity, where she is deputy director.

Joy Wan (faculty, dermatology, 2021–present) received the American Skin Association’s Research Scholar Award for Atopic Dermatitis. This funding supports emerging leaders in dermatology who are focused on understanding and finding a cure for melanoma and other skin diseases.

The Paul G. Allen Family Foundation named Kenneth Witwer (Ph.D.; fellow, pathobiology, 2010–11; faculty, pathobiology, 2011–present; faculty, neurology, 2015–present) a 2023 Allen Distinguished Investigator and awarded him funds to develop technologies, design approaches and uncover insights into biological properties of extracellular vesicles and cell communications.